Leah Kuntz

Just because a patient has anxiety or past trauma does not mean they cannot enjoy this spooky holiday…

Positive results were just released from 2 phase 3 clinical trials evaluating centanafadine for the treatment of adolescents and children with ADHD.

Michael F. Myers, MD provided tips and advice to clinicians who might be dealing with a patient contemplating suicide.

Tony Thrasher, DO, DFAPA, shared his thoughts on emergency psychiatry: an honor and a great stressor.

Here’s why you should initiate clozapine sooner in patients with treatment-resistant schizophrenia.

Sanjai Rao, MD, shared best practices for utilizing long-acting injectable antipsychotics at the 2023 Psychiatric Times World CME Conference.

The FDA has released a draft guide to offer their perspective and thoughts on the development of treatments for stimulant use disorder.

The relationship of this key symptom of major depressive disorder and patient burden is not well understood. These two posters covered it.

These 3 posters covered the efficacy and safety of paliperidone palmitate in patients with schizophrenia.

The senior vice president of research at the American Foundation for Suicide Prevention offers thoughts on suicide and students.

Today is International Overdose Awareness Day!

A recent survey found mental health and finances were some of the top stressors for college students.

The 988 Implementation Act was introduced on July 25. What impact will it have on care?

A phase 2A trial recently received confirmation to proceed in investigating psilocybin-assisted psychotherapy in the treatment of adult patients with IBS.

Learn more about a comprehensive system of care for those who are in crisis and need immediate access to care, aided by the new 988 Suicide & Crisis Lifeline.

Fasedienol meets trial endpoints by reducing anxiety during public speaking simulations in patients with social anxiety disorder.

According to the National Community Pharmacists Association, 97% of independent pharmacy owners reported shortages of Adderall in early 2023. As these shortages continue, here's how you can best support your patients with ADHD.

A new cognitive biotype for depression may impact symptoms and treatment outcomes.

Did you miss our APA Annual Meeting coverage?

What is it like to be a 988 counselor?

A year ago, the National Suicide Prevention Lifeline switched to its new 3-digit number, 988. What's happened since then?

Nearly 1 in 2 women compare themselves to Barbie.

New research finds depressive and anxiety symptoms impact effectiveness of cognitive behavioral therapy for insomnia.

1 in 5 respondents reported using psychedelic drugs for the purpose of self-treating anxiety, depression, or other mental illnesses.

Neuroimaging could help predict clinical response to treatment in bipolar depression.

New positive data was recently released from 5 in vitro studies investigating the potential for drug-drug interaction of mazindol.

Recognition is the first and most important step to treating behavioral and psychological symptoms of dementia.

In honor of Memorial Day...

Presenters at the 2023 APA Annual Meeting compared definitions of treatment-resistant depression.